NASA Notice of Intent To Grant a Partially Exclusive Patent License: Capcell Biologics, Inc.
[Federal Register Volume 84, Number 191 (Wednesday, October 2, 2019)] [Notices] [Pages 52539-52540] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2019-21395]
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
[Notice (19-058)]
Notice of Intent To Grant a Partially Exclusive Patent License
AGENCY: National Aeronautics and Space Administration.
ACTION: Notice of intent to grant a partially-exclusive patent license.
SUMMARY: NASA hereby gives notice of its intent to grant a partially exclusive patent license in the United States to practice the invention described and claimed in U.S. Patent 9,770,405 entitled, “Biocompatible Capsules and Methods of Making,” to Capcell Biologics, Inc. having its principal place of business in New York, NY. The fields of use may be limited to health and medicine. The patent rights in this invention, directed to Health, Medicine, and Biotechnology, have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. NASA has not yet made a determination to grant the requested license and may deny the requested license even if no objections are submitted within the comment period.
DATES: The prospective partially exclusive license may be granted unless NASA receives written objections, including evidence and argument no later than October 17, 2019 that establish that the grant of the license would not be consistent with the requirements regarding the licensing of federally owned inventions as set forth in the Bayh-Dole Act and implementing regulations. Competing applications completed and received by NASA no later than October 17, 2019 will also be treated as objections to the grant of the contemplated partially exclusive license. Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act.
ADDRESSES: Objections relating to the prospective license may be submitted to Patent Counsel, Office of Chief Counsel, NASA Ames Research Center, Mail Stop 202A-4, Moffett Field, CA 94035-1000. (650) 604-0887; Fax (650) 604-2767.
FOR FURTHER INFORMATION CONTACT: Robert M. Padilla, Chief Patent Counsel, Office of Chief Counsel, NASA Ames Research Center, Mail Stop 202A-4, Moffett Field, CA 94035-1000. (650) 604-0887; Fax (650) 604- 2767.
SUPPLEMENTARY INFORMATION: This Notice of Intent to Grant a Partially- Exclusive Patent License is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). The patent rights in this invention have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially-exclusive patent license will comply with the requirements of 35 U.S.C. 209 and 37 CFR. 404.7. Information about other NASA inventions available for licensing can be found online at http://technology.nasa.gov.
William T. McMurry, Deputy General Counsel. [FR Doc. 2019-21395 Filed 10-1-19; 8:45 am] BILLING CODE 7510-13-P
